Despite of the globally challenging times Vetter continues its high performance iat the 2021 CMO Leadership Awards - successfully winning five core categories.

 

 “Yet again, Vetter is honored to be a winner of the CMO Leadership Awards as determined by our most important judges – our global customers,” said Vetter Managing Director Peter Soelkner.

 

Succesful performance in five core categories

The Contract Development and Manufacturing Organization (CDMO) headquartered in Ravensburg was able to score with strong performances in the areas of quality, expertise, compatibility, capabilitiesand service.  Vetter was also the recipient of the award in a variety of categories in previous years.

 

The globally operating CDMO stated that the result is proof of the company’s hard work in its daily efforts for customers and a motivation for continued improvement towards excellence as a solution provider.

 

Customer rankings to choose the winners

The annual CMO Leadership Award, now in its tenth year, was given by the leading trade press publication, Life Science Leader. Unlike other awards where an application process determines takes place, recipients of the CMO Leadership awards are determined by a customer ranking system. The central element is their hands-on experience with the service providers they have actually worked with.

 

“This recognition is of particular importance given the challenging and turbulent times we are all experiencing with the global Covid-19 pandemic.” Carsten Press, Vetter’s Senior Vice President Key Account Management/Supply Chain Management/Marketing added, “Winning this award in five key categories is a direct reflection of what we strive to project to our customers. It further demonstrates our stable performance for them and especially their patients.”

 

The awards honors true customer performance. As such, they represent a high level of accomplishment and signify that winning companies have attained a leading level of support for the needs of their pharma and biotech customers.

 

 “These past months reinforced the criticality of the services and partnership models provided by CDMOs to biopharma organizations of this size,” said Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma. “In fact, much of the drug development and manufacturing industry was sustained by reliable outsourcing in the face of a horrible pandemic. That reliability was a result of constant dedication to customers, and perhaps, one attribute above all – flexibility.”

 

 

 

 

 

Quellen

Vetter (2021, February 18). Vetter continues its successful performance at the 2021 CMO Leadership Awards [Press release].